lobbying_activities: 1181030

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1181030	a7dff21d-6582-4aa7-b991-fda885e5859d	Q4	RED+BLUE STRATEGIES	400693064	PEW CHARITABLE TRUSTS	2011	fourth_quarter	HCR	H.R. 2182/S.1734 - The Generating Antibiotic Incentives Now Act of 2011. Supporting work to increase innovation in the development of new antibiotics. S. 1584 - The Drug Safety and Accountability Act of 2011. Supporting upstream supply chain safety issues. S. 3026 - Safeguarding America's Pharmaceuticals Act of 2011. Supporting downstream supply chain issues. Implementation and rulemaking related to the Physician Payment Sunshine Act - A Medicare-related provision in the Health Reform Law focused on increasing systemic transparency. Work related to treatment of medical devices in the upcoming FDA user fee arena.	Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE	25000		0	0	2011-12-29T16:55:51-05:00